These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 38607917)

  • 41. Into the Cauldron of the Variant Soup: Insights into the Molecular Epidemiology and Transition to Endemicity of SARS-CoV-2 in Cyprus (November 2022-February 2024).
    Chrysostomou AC; The Comessar Network ; Kostrikis LG
    Viruses; 2024 Oct; 16(11):. PubMed ID: 39599801
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Discovery of anti-SARS-CoV-2 S2 protein antibody CV804 with broad-spectrum reactivity with various beta coronaviruses and analysis of its pharmacological properties in vitro and in vivo.
    Tsugawa Y; Furukawa K; Ise T; Takayama M; Ota T; Kuroda T; Shano S; Hashimoto T; Konishi H; Ishihara T; Sato M; Kamada H; Fukao K; Shishido T; Yoshikawa M; Takahashi T; Nagata S
    PLoS One; 2024; 19(12):e0300297. PubMed ID: 39621673
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tracing the origin of SARS-CoV-2 omicron-like spike sequences detected in an urban sewershed: a targeted, longitudinal surveillance study of a cryptic wastewater lineage.
    Shafer MM; Bobholz MJ; Vuyk WC; Gregory DA; Roguet A; Haddock Soto LA; Rushford C; Janssen KH; Emmen IE; Ries HJ; Pilch HE; Mullen PA; Fahney RB; Wei W; Lambert M; Wenzel J; Halfmann P; Kawaoka Y; Wilson NA; Friedrich TC; Pray IW; Westergaard R; O'Connor DH; Johnson MC
    Lancet Microbe; 2024 Apr; 5(4):e335-e344. PubMed ID: 38484748
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Host immune responses associated with SARS-CoV-2 Omicron infection result in protection or pathology during reinfection depending on mouse genetic background.
    Singh G; Warang P; García-Bernalt Diego J; Chang L; Bykov Y; Singh S; Pache L; Cuadrado-Castano S; Webb B; Garcia-Sastre A; Schotsaert M
    Res Sq; 2023 Nov; ():. PubMed ID: 38077015
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SARS-CoV-2 Omicron (B.1.1.529) shows minimal neurotropism in a double-humanized mouse model.
    Alves RPDS; Wang YT; Mikulski Z; McArdle S; Shafee N; Valentine KM; Miller R; Verma SK; Batiz FAS; Maule E; Nguyen MN; Timis J; Mann C; Zandonatti M; Alarcon S; Rowe J; Kronenberg M; Weiskopf D; Sette A; Hastie K; Saphire EO; Festin S; Kim K; Shresta S
    Antiviral Res; 2023 Apr; 212():105580. PubMed ID: 36940916
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative Analysis of African and Asian Lineage-Derived Zika Virus Strains Reveals Differences in Activation of and Sensitivity to Antiviral Innate Immunity.
    Esser-Nobis K; Aarreberg LD; Roby JA; Fairgrieve MR; Green R; Gale M
    J Virol; 2019 Jul; 93(13):. PubMed ID: 31019057
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study.
    Sridhar S; Joaquin A; Bonaparte MI; Bueso A; Chabanon AL; Chen A; Chicz RM; Diemert D; Essink BJ; Fu B; Grunenberg NA; Janosczyk H; Keefer MC; Rivera M DM; Meng Y; Michael NL; Munsiff SS; Ogbuagu O; Raabe VN; Severance R; Rivas E; Romanyak N; Rouphael NG; Schuerman L; Sher LD; Walsh SR; White J; von Barbier D; de Bruyn G; Canter R; Grillet MH; Keshtkar-Jahromi M; Koutsoukos M; Lopez D; Masotti R; Mendoza S; Moreau C; Ceregido MA; Ramirez S; Said A; Tavares-Da-Silva F; Shi J; Tong T; Treanor J; Diazgranados CA; Savarino S
    Lancet Infect Dis; 2022 May; 22(5):636-648. PubMed ID: 35090638
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SARS-CoV-2 N protein recruits G3BP to double membrane vesicles to promote translation of viral mRNAs.
    Long S; Guzyk M; Perez Vidakovics L; Han X; Sun R; Wang M; Panas MD; Urgard E; Coquet JM; Merits A; Achour A; McInerney GM
    Nat Commun; 2024 Dec; 15(1):10607. PubMed ID: 39638802
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Integrated all-atom and coarse-grained simulations uncover structural, dynamics and energetic shifts in SARS-CoV-2 JN.1 and BA.2.86 variants.
    Sharma A; Maurya S; Tripathi T; Padhi AK
    Acta Trop; 2024 Dec; 260():107444. PubMed ID: 39471972
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents.
    Uraki R; Halfmann PJ; Iida S; Yamayoshi S; Furusawa Y; Kiso M; Ito M; Iwatsuki-Horimoto K; Mine S; Kuroda M; Maemura T; Sakai-Tagawa Y; Ueki H; Li R; Liu Y; Larson D; Fukushi S; Watanabe S; Maeda K; Pekosz A; Kandeil A; Webby RJ; Wang Z; Imai M; Suzuki T; Kawaoka Y
    Nature; 2022 Dec; 612(7940):540-545. PubMed ID: 36323336
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular mechanisms of thalidomide effectiveness on COVID-19 patients explained: ACE2 is a new ΔNp63α target gene.
    Monteonofrio L; Virdia I; Pozzi S; Quadri R; Amendolare A; Marzano F; Braile M; Sulfaro V; Paroni M; Tullo A; Soddu S; Guerrini L
    J Mol Med (Berl); 2024 Nov; 102(11):1371-1380. PubMed ID: 39294414
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Australia in 2030: what is our path to health for all?
    Backholer K; Baum F; Finlay SM; Friel S; Giles-Corti B; Jones A; Patrick R; Shill J; Townsend B; Armstrong F; Baker P; Bowen K; Browne J; Büsst C; Butt A; Canuto K; Canuto K; Capon A; Corben K; Daube M; Goldfeld S; Grenfell R; Gunn L; Harris P; Horton K; Keane L; Lacy-Nichols J; Lo SN; Lovett RW; Lowe M; Martin JE; Neal N; Peeters A; Pettman T; Thoms A; Thow AMT; Timperio A; Williams C; Wright A; Zapata-Diomedi B; Demaio S
    Med J Aust; 2021 May; 214 Suppl 8():S5-S40. PubMed ID: 33934362
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cell Fusion Induced by a Fusion-Active Form of Human Cytomegalovirus Glycoprotein B (gB) Is Inhibited by Antibodies Directed at Antigenic Domain 5 in the Ectodomain of gB.
    Reuter N; Kropff B; Schneiderbanger JK; Alt M; Krawczyk A; Sinzger C; Winkler TH; Britt WJ; Mach M; Thomas M
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641474
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exposure of progressive immune dysfunction by SARS-CoV-2 mRNA vaccination in patients with chronic lymphocytic leukemia: A prospective cohort study.
    Qin K; Honjo K; Sherrill-Mix S; Liu W; Stoltz RM; Oman AK; Hall LA; Li R; Sterrett S; Frederick ER; Lancaster JR; Narkhede M; Mehta A; Ogunsile FJ; Patel RB; Ketas TJ; Cruz Portillo VM; Cupo A; Larimer BM; Bansal A; Goepfert PA; Hahn BH; Davis RS
    PLoS Med; 2023 Jun; 20(6):e1004157. PubMed ID: 37384638
    [TBL] [Abstract][Full Text] [Related]  

  • 55. FUS/TLS Suppresses Enterovirus Replication and Promotes Antiviral Innate Immune Responses.
    Xue YC; Ng CS; Mohamud Y; Fung G; Liu H; Bahreyni A; Zhang J; Luo H
    J Virol; 2021 May; 95(12):. PubMed ID: 33827951
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SARS-CoV-2 Omicron BA.1 Variant Infection of Human Colon Epithelial Cells.
    Antia A; Alvarado DM; Zeng Q; Casorla-Perez LA; Davis DL; Sonnek NM; Ciorba MA; Ding S
    Viruses; 2024 Apr; 16(4):. PubMed ID: 38675974
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A robust SARS-CoV-2 replication model in primary human epithelial cells at the air liquid interface to assess antiviral agents.
    Do TND; Donckers K; Vangeel L; Chatterjee AK; Gallay PA; Bobardt MD; Bilello JP; Cihlar T; De Jonghe S; Neyts J; Jochmans D
    Antiviral Res; 2021 Aug; 192():105122. PubMed ID: 34186107
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Population Immunity and Covid-19 Severity with Omicron Variant in South Africa.
    Madhi SA; Kwatra G; Myers JE; Jassat W; Dhar N; Mukendi CK; Nana AJ; Blumberg L; Welch R; Ngorima-Mabhena N; Mutevedzi PC
    N Engl J Med; 2022 Apr; 386(14):1314-1326. PubMed ID: 35196424
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Primary SARS-CoV-2 variant of concern infections elicit broad antibody Fc-mediated effector functions and memory B cell responses.
    van der Straten K; Guerra D; Kerster G; Claireaux M; Grobben M; Schriek AI; Boyd A; van Rijswijk J; Tejjani K; Eggink D; Beaumont T; de Taeye SW; de Bree GJ; Sanders RW; van Gils MJ
    PLoS Pathog; 2024 Aug; 20(8):e1012453. PubMed ID: 39146376
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Application of MALDI-TOF MS and machine learning for the detection of SARS-CoV-2 and non-SARS-CoV-2 respiratory infections.
    Yegorov S; Kadyrova I; Korshukov I; Sultanbekova A; Kolesnikova Y; Barkhanskaya V; Bashirova T; Zhunusov Y; Li Y; Parakhina V; Kolesnichenko S; Baiken Y; Matkarimov B; Vazenmiller D; Miller MS; Hortelano GH; Turmukhambetova A; Chesca AE; Babenko D
    Microbiol Spectr; 2024 May; 12(5):e0406823. PubMed ID: 38497716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.